Evidence map›Paper›PMID 32163462›Full record

ArticlePloS one2020

Transient pentameric IgM fulfill biological function-Effect of expression host and transfection on IgM properties.

Julia Hennicke, Linda Schwaigerlehner, Clemens Grünwald-Gruber, Isabelle Bally, Wai Li Ling, Nicole Thielens, Jean-Baptiste Reiser, Renate Kunert

Abstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Glycosylation of Plant-Produced Immunoglobulins.Experientia supplementum (2012) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julia HennickeDepartment of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria.
Linda SchwaigerlehnerDepartment of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria.
Clemens Grünwald-GruberDepartment of Chemistry, University of Natural Resources and Life Sciences, Vienna, Austria.
Isabelle BallyInstitut de Biologie Structurale, UMR 5075, Université Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.
Wai Li LingInstitut de Biologie Structurale, UMR 5075, Université Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.
Nicole ThielensInstitut de Biologie Structurale, UMR 5075, Université Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.
Jean-Baptiste ReiserInstitut de Biologie Structurale, UMR 5075, Université Grenoble Alpes, CEA, CNRS, IBS, Grenoble, France.
Renate KunertDepartment of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria.ORCID 0000-0002-3397-3621

Funding

Austrian Science Fund FWF W 1224
6 · The paper itself

Abstract

Recombinant production of IgM antibodies poses a special challenge due to the complex structure of the proteins and their not yet fully elucidated interactions with the immune effector proteins, especially the complement system. In this study, we present transient expression of IgM antibodies (IgM617, IgM012 and IgM012_GL) in HEK cells and compared it to the well-established stable expression system in CHO cells. The presented workflow investigates quality attributes including productivity, polymer distribution, glycosylation, antibody structure and activation of the classical complement pathway. The HEK293E transient expression system is able to generate comparable amounts and polymer distribution as IgM stably produced in CHO. Although the glycan profile generated by HEK293E cells contained a lower degree of sialylation and a higher portion of oligomannose structures, the potency to activate the complement cascade was maintained. Electron microscopy also confirmed the structural integrity of IgM pentamers produced in HEK293E cells, since the conventional star-shaped structure is observed. From our studies, we conclude that the transient expression system provides an attractive alternative for rapid, efficient and high-throughput production of complex IgM antibodies with slightly altered post-translational modifications, but comparable structure and function.

Indexed as

AnimalsCHO CellsComplement ActivationComplement C1qCricetinaeCricetulusGlycosylationHEK293 CellsHumansImmunoglobulin MMicroscopy, Electron, TransmissionOligosaccharidesPlasmidsTransfectionComplement C1qImmunoglobulin MoligomannosideOligosaccharides

Identifiers

PMID32163462
PMCPMC7067452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.